A detailed history of Baird Financial Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Baird Financial Group, Inc. holds 4,035,607 shares of JNJ stock, worth $627 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
4,035,607
Previous 4,006,875 0.72%
Holding current value
$627 Million
Previous $634 Million 6.94%
% of portfolio
1.24%
Previous 1.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $4.15 Million - $4.53 Million
28,732 Added 0.72%
4,035,607 $590 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $12.5 Million - $13.1 Million
80,273 Added 2.04%
4,006,875 $634 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $16.2 Million - $17.7 Million
111,125 Added 2.91%
3,926,602 $615 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $1.1 Million - $1.23 Million
-7,057 Reduced 0.18%
3,815,477 $594 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $147 Million - $159 Million
-954,779 Reduced 19.99%
3,822,534 $633 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $20 Million - $23.9 Million
132,713 Added 2.86%
4,777,313 $740 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $18.2 Million - $20.3 Million
112,925 Added 2.76%
4,204,892 $687 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $25.7 Million - $28.4 Million
152,511 Added 3.87%
4,091,967 $726 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $36 Million - $40.9 Million
227,695 Added 6.13%
3,939,456 $698 Million
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $57.3 Million - $63.5 Million
367,215 Added 10.98%
3,711,761 $635 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $9.97 Million - $11.1 Million
61,740 Added 1.88%
3,344,546 $540 Million
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $12.8 Million - $13.7 Million
-80,142 Reduced 2.38%
3,282,806 $541 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $14.3 Million - $15.9 Million
93,558 Added 2.86%
3,362,948 $553 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $11.1 Million - $12.7 Million
80,597 Added 2.53%
3,269,390 $515 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $4.66 Million - $5.11 Million
33,222 Added 1.05%
3,188,793 $475 Million
Q2 2020

Oct 22, 2020

BUY
$128.81 - $155.51 $22.1 Million - $26.7 Million
171,613 Added 5.75%
3,155,571 $444 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $6.61 Million - $7.98 Million
-51,312 Reduced 1.69%
2,983,958 $429 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $7.08 Million - $9.81 Million
63,690 Added 2.14%
3,035,270 $398 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $2.37 Million - $2.72 Million
18,552 Added 0.63%
2,971,580 $433 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $18.7 Million - $20.9 Million
-147,217 Reduced 4.75%
2,953,028 $382 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $221 Million - $243 Million
1,682,863 Added 118.73%
3,100,245 $432 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $32.1 Million - $35.7 Million
-255,308 Reduced 15.26%
1,417,382 $198 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $9.11 Million - $11 Million
74,161 Added 4.64%
1,672,690 $216 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $3.47 Million - $4.08 Million
28,548 Added 1.82%
1,598,529 $223 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $11.6 Million - $12.8 Million
97,240 Added 6.6%
1,569,981 $191 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $3.45 Million - $4.08 Million
27,571 Added 1.91%
1,472,741 $189 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $2.33 Million - $2.55 Million
17,783 Added 1.25%
1,445,170 $202 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $3.24 Million - $3.39 Million
25,026 Added 1.78%
1,427,387 $186 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,402,361
1,402,361 $186 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.